Together with the Chemical Biology Core Facility (CBCF) at EMBL in Heidelberg, Cornelia successfully completed the pilot screen for our largest screen, yet to come.
Over the summer 2025, we will be screening a total of 100k chemical fragments to get a step closer to our goal of developing an inhibitor against colorectal cancer stem cells.
Stay tuned to see what we can achieve in this fruitful collaboration!
